Skip to Main Content

Paper Details

Genetic and epigenetic inactivation of <i>SESTRIN1</i> controls mTORC1 and response to EZH2 inhibition in follicular lymphoma.
Sci Transl Med
44
2017
6q deletion, B cell lymphoma, EZH2, EZH2 mutant, EZH2 mutant lymphomas, FL, Follicular lymphoma, RRAGC, RapaLink, SESTRIN1, chromosome 6q, follicular lymphoma, lymphoma, lymphoma-specific, lymphoma-specific EZH2 gain-of-function mutation, lymphomas, mRNA, mTOR, mTORC1, mammalian target of rapamycin complex 1, p53, rapamycin, tumor
Author NameAffiliation
Sohrab P ShahUniversity of British Columbia
Sohrab P Shah
Ari MelnickWeill Cornell Medical College, Cornell University
Giovanni CirielloUniversity of Lausanne
Giovanni CirielloUniversity of Lausanne
  • 1 - 5

Datasets

Release 1.2